Genmab A (GMAB) Exchange Rate Effect (2023 - 2026)

Genmab A has reported Exchange Rate Effect for 4 years, with the latest figure at -$11.0 million in Q1 2026.

• For the quarter ending Q1 2026, Exchange Rate Effect fell 237.5% year-over-year to -$11.0 million; the trailing twelve-month figure through Mar 2026 stood at $7.0 million (down 73.08% YoY), and the FY2025 full-year result was $3.0 million, down 95.24% from the prior year.
• Exchange Rate Effect for Q1 2026 stood at -$11.0 million, down from $7.0 million in the prior quarter.
• The five-year high for Exchange Rate Effect was $34.0 million in Q3 2024, with the low at -$15.0 million in Q2 2024.
• Historically, Exchange Rate Effect has averaged $1.6 million across 4 years, with a median of $1.0 million in 2024.
• Annual changes were most pronounced in 2025 — Exchange Rate Effect surged 900.0% — and 2026, when it tumbled 237.5%.
• Genmab A's Exchange Rate Effect stood at -$12.0 million in 2023, then jumped by 383.33% to $34.0 million in 2024, then tumbled by 79.41% to $7.0 million in 2025, then plunged by 257.14% to -$11.0 million in 2026.
• The last three Exchange Rate Effect figures came in at -$11.0 million (Q1 2026), $7.0 million (Q3 2025), and $3.0 million (Q2 2025), per Business Quant data.